Evoke Pharma, Inc. (EVOK)
11.00
0.00 (0.00%)
USD |
NASDAQ |
May 22, 16:00
Evoke Pharma EPS Diluted (Quarterly) : -0.4521 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | -0.2988 |
| Assertio Holdings, Inc. | -2.931 |
| Johnson & Johnson | 2.141 |
| Eli Lilly & Co. | 8.255 |
| Merck & Co., Inc. | -1.715 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.156M |
| Revenue (Quarterly) | 4.284M |
| Total Expenses (Quarterly) | 5.440M |
| Enterprise Value | 12.48M |
| Gross Profit Margin (Quarterly) | 97.62% |
| Profit Margin (Quarterly) | -26.99% |
| Earnings Yield | -21.66% |
| Normalized Earnings Yield | -21.66 |